MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the year ending 2025-12-31.

Income Overview

Net Income
-$17,342K
Unit: Thousand (K) dollars

Income Statement
2025-12-31
Research and development
2,815
General and administrative
9,280
Impairment loss on other intangible assets
5,180
Total operating expenses
17,275
Loss from operations
-17,275
Interest income
1
Interest expense
949
Gain on settlement of current liabilities
2,984
Loss on debt extinguishment
-3,164
Change in fair value of warrant liabilities
775
Loss on derivative liability
-230
Foreign currency exchange gains (losses), net
-443
Total other income, net
-1,026
Net loss before income taxes
-18,301
Income tax benefit
-1,003
Net loss
-17,298
Foreign currency translation adjustment
-44
Total other comprehensive income, net of tax
-44
Total comprehensive loss
-17,342
Basic EPS
0
Diluted EPS
0
Basic Average Shares
67,328,128,638
Diluted Average Shares
67,328,128,638
Unit: Thousand (K) dollars (except for numbers of shares and EPS).

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Total comprehensiveloss-$17,342K Net loss-$17,298K Total othercomprehensive income, net of...-$44K Income tax benefit-$1,003K Net loss beforeincome taxes-$18,301K Foreign currencytranslation adjustment-$44K Loss from operations-$17,275K Total other income,net-$1,026K Gain on settlement ofcurrent liabilities$2,984K Change in fair value ofwarrant liabilities$775K Interest income$1K Total operatingexpenses$17,275K Loss on debtextinguishment-$3,164K Interest expense$949K Foreign currencyexchange gains (losses),...-$443K Loss on derivativeliability-$230K General andadministrative$9,280K Impairment loss on otherintangible assets$5,180K Research and development$2,815K

Akari Therapeutics Plc (AKTX)

Akari Therapeutics Plc (AKTX)